NCT06711549

Brief Summary

The Serrato Posterosuperior Block (SPSIP) is a recently discovered technique that provides analgesia to the hemithorax, shoulders, neck and back. At an anatomical level, it has been seen that this technique allows the diffusion of local anesthetic starting from C7 proceeding dorsally up to T10 by sectioning the trapezius, latissimus dorsi, rhomboid and erector spinae muscles. The serratus anterior block (SAPB) is a technique that allows local anesthetic to be injected between the serratus anterior muscle and the intercostal muscles (deep plane) or between the latissimus dorsi muscle and the serratus anterior muscle (superficial plane), also providing analgesia at of the chest wall. This study aims to compare the analgesic efficacy of SPSIPB and SAPB in patients undergoing radical mastectomy for breast cancer

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Nov 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Nov 2024Nov 2026

First Submitted

Initial submission to the registry

October 20, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

November 20, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

12 months

First QC Date

October 20, 2024

Last Update Submit

November 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain at 0 hours after surgery

    The primary objective of the study is to evaluate whether there is a difference between SAP block and SPSIP block at 0 hours after surgery at rest measure with visual analogic scale (0-10)

    0 hours after surgery

Secondary Outcomes (6)

  • Pain at 6 hours after surgery

    6 hours after surgery

  • Pain at 12 hours after surgery

    12 hours after surgery

  • Pain at 24hours after surgery

    24 hours after surgery

  • Intraoperative Opioid consumption

    During the surgery(From patient intubation to patient extubation)

  • Postoperative Opioid consumption

    From extubation to 24 hours post-enrollment

  • +1 more secondary outcomes

Study Arms (2)

Patients receiving Serratus Posterior Superior Plane Intercostal Plane block

EXPERIMENTAL

The patients will undergosurgery after receiving an ultrasound guided serratus posterior superior intercostal plane block

Procedure: Serratus Posterior Superior Plane Intercostal Plane block

Serratus Anterior Plane Block

ACTIVE COMPARATOR

The patients will undergosurgery after receiving an ultrasound guided serratus anterior plane block

Procedure: Serratus Anterior Plane block

Interventions

Under ultrasound guidance; local anesthetic will be injected in the plane between the posterior aspect of the serratus posterior superior plane and the ribs

Patients receiving Serratus Posterior Superior Plane Intercostal Plane block

Under ultrasound guidance; local anesthetic will be injected in the plane between the posterior aspect of the serratus anterior and the external intercostal muscles and ribs

Serratus Anterior Plane Block

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult Patient ( \> 18 years)
  • Informed consent
  • American Society of Anaesthesiologis Phisical Status I to III
  • Patients undergoing for mastectomy with sentinel lynphnode byopsy/axillary clearence

You may not qualify if:

  • Pregnant women
  • Allergy to any drug present in the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Rogobete AF, Sandesc D. General Anesthesia as a Multimodal Individualized Clinical Concept. Medicina (Kaunas). 2022 Jul 19;58(7):956. doi: 10.3390/medicina58070956.

  • Nelson G, Fotopoulou C, Taylor J, Glaser G, Bakkum-Gamez J, Meyer LA, Stone R, Mena G, Elias KM, Altman AD, Bisch SP, Ramirez PT, Dowdy SC. Enhanced recovery after surgery (ERAS(R)) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update. Gynecol Oncol. 2023 Jun;173:58-67. doi: 10.1016/j.ygyno.2023.04.009. Epub 2023 Apr 21.

MeSH Terms

Conditions

Pain, PostoperativeBreast Neoplasms

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Valentina Scaduto

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

October 20, 2024

First Posted

December 2, 2024

Study Start

November 20, 2024

Primary Completion

November 1, 2025

Study Completion (Estimated)

November 1, 2026

Last Updated

December 2, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share